Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
04/2010
04/27/2010US7704543 Obtaining a high density, reproducible and uniform coverage of a solid surface suitable for solid state synthesis and biosynthesis; aminosilanation of activated glass reacted with a diester of trimesic acid and N-hydroxysuccinimide followed by hydrolysis; attaching of DNA, proteins, biopolymers
04/27/2010CA2493667C Vanilloid receptor ligands and their use in treatments
04/27/2010CA2449180C Viral polymerase inhibitors
04/27/2010CA2345118C Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
04/22/2010WO2010045580A1 Sphingosine-1-phosphate receptor antagonists
04/22/2010WO2010045266A1 Therapeutic antiviral peptides
04/22/2010WO2010045188A1 Heteroaryl substituted indole compounds useful as mmp-13 inhibitors
04/22/2010WO2010044753A1 Novel benzylidene-indolinone and their medical and diagnostic uses
04/22/2010WO2010044130A1 Aromatic amine derivative and organic electroluminescent device using the same
04/22/2010WO2010043711A1 Allosteric protein kinase modulators
04/22/2010WO2010043693A1 Host material for light-emitting diodes
04/22/2010WO2010043691A1 N-phenyl carbazole-based host material for light-emitting diodes
04/22/2010WO2010043584A1 Salicylic acid derivatives being farnesyl pyrophosphate synthase activity inhibitors
04/22/2010WO2010043155A1 Novel purpurone-type alkaloids, process for their preparation, and their usage as medications
04/22/2010WO2010043000A1 S1p receptors modulators and their use thereof
04/22/2010WO2010042998A1 S1p receptors modulators
04/22/2010US20100099891 Estimation of protein-compound interaction and rational design of compound library based on chemical genomic information
04/22/2010US20100099890 Anthracene derivative and light-emitting devices, electronic devices, and lighting device using the anthracene derivative
04/22/2010US20100099874 Transannular rearrangement of activated lactams
04/22/2010US20100099729 Nitric oxide donor compounds
04/22/2010US20100098634 Imaging Agents Useful for Identifying AD Pathology
04/22/2010US20100098631 Novel-2-Heteroaryl Substituted Indoles 695
04/22/2010US20100098629 Novel Amides Acting on the Adenosine Receptors
04/22/2010US20100096252 Photolabile dinitroindolinyl based compounds
04/22/2010CA2740783A1 Sphingosine-1-phosphate receptor antagonists
04/22/2010CA2740728A1 Therapeutic antiviral peptides
04/22/2010CA2740484A1 S1p receptors modulators and their use thereof
04/22/2010CA2739901A1 S1p receptors modulators
04/22/2010CA2738929A1 Heteroaryl substituted indole compounds useful as mmp-13 inhibitors
04/22/2010CA2736206A1 Salicylic acid derivatives being farnesyl pyrophosphate synthase activity inhibitors
04/21/2010EP2177572A1 Indolium compound and optical recording material using the compound
04/21/2010EP2177511A2 Process for preparing 3,6-disubstituted azabicyclo derivatives
04/21/2010EP2177510A1 Allosteric protein kinase modulators
04/21/2010EP2176221A1 Indole indane amide compounds useful as cb2 agonists and method
04/21/2010EP2176220A2 Pyrrolidin-2-one derivatives as androgen receptor modulator
04/21/2010EP2176210A1 Degradation accelerator for polymers and polymer article comprising it
04/21/2010EP1971575B1 Anthraquinone derivatives as markers for liquids
04/21/2010EP1442016B1 1h-indole derivatives as a highly selective cyclooxygenase-2 inhibitor
04/21/2010EP1258252B1 Integrin expression inhibitors
04/21/2010CN1522246B Triamide-substituted indoles, benzofuranes and benzothiophenes
04/21/2010CN101696232A Peptidomimetic protease inhibitors
04/21/2010CN101696185A Synthesizing method of 6-nitro-S-(-)-indoline-2-carboxylic acid
04/21/2010CN101696184A Iodine-phenyl-substituted cyclic cetoenols
04/20/2010US7700642 Reacting 3-(4-fluorophenyl)-1-isopropyl-1H-indole, 3,3-dimethoxypropionate, acetic acid and phosphorus oxychloride obtaining trans-3-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]acrylate
04/20/2010US7700586 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
04/20/2010CA2418744C Novel aminocyclohexane derivatives
04/20/2010CA2417475C Composes azabicycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacterien
04/20/2010CA2358925C Compositions and methods for use in targeting vascular destruction
04/20/2010CA2348741C Nitrosasted and nitrosylated nonsteroidal antiinflammatory compounds, comositions and methods of use
04/20/2010CA2319680C Compounds and compositions for delivering active agents
04/20/2010CA2279331C Compounds and compositions for delivering active agents
04/15/2010WO2010042867A2 Activators of human pyruvate kinase
04/15/2010WO2010042445A1 Carbazole compounds and therapeutic uses of the compounds
04/15/2010WO2010041872A2 Novel compound and organic electronic device using same
04/15/2010WO2010041574A1 Fullerene derivative, composition and organic photoelectric conversion element
04/15/2010WO2009157015A8 Synthesis of 1-(carbazol-4-yloxy)-3-[[2-(o- methoxyphenoxy)ethyl]amino]-2-propanol
04/15/2010US20100093985 Use of at least one cytosolic phospholipase a2 inhibitor as a medicine for symptomatic treatment of mucoviscidosis
04/15/2010US20100093823 Steroidal compounds as melanogenesis modifiers and uses thereof
04/15/2010US20100093785 Diamine derivatives
04/15/2010US20100093708 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
04/15/2010US20100093707 Acid amide derivatives, process for their production and pesticides containing them
04/15/2010US20100093671 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
04/15/2010US20100093068 System and methods for nucleic acid sequencing of single molecules by polymerase synthesis
04/15/2010US20100092496 drug-ligand conjugates that are potent cytotoxins; stabilized therapeutic agents and markers; exhibit high specificity of action, reduced toxicity, and improved stability in blood ; antitumors
04/15/2010US20100089439 Cbp compound
04/15/2010DE102008050841A1 Neue Materialien für organische Elektrolumineszenzvorrichtungen New materials for organic electroluminescent
04/15/2010CA2740148A1 Activators of human pyruvate kinase
04/15/2010CA2736097A1 Carbazole compounds and therapeutic uses of the compounds
04/14/2010EP2173707A1 Pleuromutilin derivatives and their use as antimicrobials
04/14/2010EP1951668B1 Novel process for the preparation of thoc
04/14/2010EP1919869B1 Indole derivatives as ppar activators
04/14/2010EP1694410B1 Cyclopropane derivatives and pharmaceutical use thereof
04/14/2010EP1685098B1 Ortho-substituted pentafluoride sulfanyl-benzenes, method for the production thereof and the use thereof in the form of valuable synthesis intermediate stages
04/14/2010EP1656141B1 Treatment for alzheimer s disease and related conditions
04/14/2010EP1537078B1 Indoles having anti-diabetic activity
04/14/2010EP1335901B1 Pharmaceutically active sulfanilide derivatives
04/14/2010CN101693672A Peptidomimetic protease inhibitors
04/14/2010CN101225070B Antineoplastic medicament
04/14/2010CN101139309B Asymmetric star-radiation shaped triphenylamine compound and uses thereof
04/13/2010US7696356 heating a mixture of 1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one, an aldehyde and HCl (mineral acid) to provide 1,2,3,9-tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one; and isolating the 1,2,3,9-tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one ( without using secondary amine catalyst)
04/13/2010US7696246 Useful in female hormone replacement therapy and as modulators of fertility; therapy of dysfunctional uterine bleeding, dysmenorrhea, endometriosis, leiomyomas (uterine fibroids), hot flashes, mood disorders, meningiomas, cancer; 6-(bis-2,2,2-Trifluoroethyl)amino-4-trifluoromethylcoumarin
04/13/2010US7696241 sarcopenia,frailty or age-related functional decline; nonsteroidal, nontoxic; side effect reduction;2-Chloro-4-(-4-hydroxy-1-oxo-hexahydrocyclopenta[c]pyrrol-2(1H)-yl)-3-methylbenzonitrile
04/13/2010US7696240 3-Methyl-1-naphthalen-1-ylmethyl-1H-indole-2-carboxylic acid; inhibit chymase; allergic, inflammatory and/or fibrotic diseases, such as allergy, asthma, peripheral arterial occlusive disease
04/13/2010US7696239 Tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators
04/13/2010US7696231 Therapy, prevention of metabolism disorders; insulin resistance; antidiabetic agents; hypoglycemic agents; anticholesterol agents; obesity; polycystic ovarian syndrome
04/13/2010US7696186 7,9-substituted tetracycline compounds
04/13/2010US7695793 biarylethylene compound containing iminium group; a light absorber
04/13/2010CA2336807C Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
04/08/2010WO2010039982A1 Crth2 modulators
04/08/2010WO2010039545A2 1,2-benzisothiazolinone and isoindolinone derivatives
04/08/2010WO2010038803A1 2-indoleacrylamide analogue
04/08/2010WO2010037190A1 Compounds derived from 2-(3-methylenedioxy)-benzoyl indol
04/08/2010WO2010037172A1 Antioxidant compounds and methods of their use
04/08/2010WO2010006234A3 Anticancer oral formulation
04/08/2010WO2009018662A9 Renin inhibitors
04/08/2010US20100087661 Method for the preparation of 5-benzyloxy-2-(4-benzyloxphenyl)-3-methyl-1h-indole
04/08/2010US20100087660 Synthesis of amines and intermediates for the synthesis thereof
04/08/2010US20100087659 Norbornene compounds with cross-linkable groups and their derivatives
04/08/2010US20100087505 Compounds Having Aryl-Sulphonamidic Structure Useful As Metalloproteases Inhibitors
04/08/2010US20100087484 Aminoalkoxy aryl sulfonamide compounds and their use as 5-ht6 ligands
1 ... 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 ... 458